EX-10.1 2 a17-4715_1ex10d1.htm EX-10.1 Incyte Corporation February 17, 2017 The Holders set forth on the Signature page to this AgreementLetter Agreement • May 5th, 2020
Contract Type FiledMay 5th, 2020Re: 0.375% Convertible Senior Notes due 2018 (CUSIP No. 45337CAK8) of Incyte Corporation (“2018 Notes”) and 1.25% Convertible Senior Notes due 2020 (CUSIP No. 45337CAL6) of Incyte Corporation (“2020 Notes”)
Re: 0.375% Convertible Senior Notes due 2018 (CUSIP No. 45337CAK8) of Incyte Corporation (“2018 Notes”) and 1.25% Convertible Senior Notes due 2020 (CUSIP No. 45337CAL6) of Incyte Corporation (“2020 Notes”)Letter Agreement • February 21st, 2017 • Incyte Corp • Services-commercial physical & biological research
Contract Type FiledFebruary 21st, 2017 Company IndustryBy entering into this letter agreement (this “Agreement”), each party signing this Agreement under the heading “HOLDER” on the signature page hereto (each a “Holder” and, collectively, the “Holders”) and Incyte Corporation, a Delaware corporation (the “Company”) irrevocably agree as follows: